In our present study, 961 patients carrying an invasive form of breast cancer were recruited to investigate the clinical importance of identifying the preoperative serum levels of various tumor markers such as CEA, CA15-3, and CA125. This evidence concerns the gene CEACAM5 and breast cancer.